Su Hee Kim | Biomedical device | Best Researcher Award

Published on by Academic Awards

Dr. Su Hee Kim | Biomedical device | Best Researcher Award

Dr. Su Hee Kim, Medifab co, Ltd., South Korea

Dr. Su Hee Kim, an accomplished researcher in biomedical engineering, specializes in regenerative medicine, biomaterials, and 3D bioprinting. She serves as the R&D Director at Medifab Co., Ltd., contributing to innovations in tissue engineering and healthcare materials. With a Ph.D. in Nano, Bio, and Information Technology from Korea University, her research has led to numerous patents and publications. Recognized with awards like the Best Research Award in Advanced Healthcare Materials, Dr. Kim’s pioneering work enhances patient-specific medical solutions.

Publication Profile

Scopus

Education πŸŽ“

Dr. Kim earned her Ph.D. in Nano, Bio, and Information Technology from the KU-KIST Graduate School of Converging Science and Technology at Korea University (2016). Prior to that, she completed her M.S. in Biotechnology from Korea University (2010) and a B.S. in Applied Chemistry from Dongduk Women’s University (2008). Her interdisciplinary academic background has equipped her with the expertise to excel in biomaterials research, bioprinting technology, and regenerative medicine.

Experience πŸ’Ό

Dr. Kim has held leadership and research positions, including her current role as R&D Director at Medifab Co., Ltd. (2021-present). She served as a Senior Researcher and Team Lead at AMRC Korea (2019-2020) and a Research Engineer at AMRC Korea (2017-2019). Additionally, she gained extensive experience as a Post-Doc and Researcher at the Korea Institute of Science and Technology (KIST) from 2007 to 2017. Her career is defined by impactful contributions to biomaterial development and translational medical research.

Awards and Honors πŸ†

Dr. Kim’s excellence in research has been acknowledged with several prestigious awards, including the Best Research Award in Advanced Healthcare Materials (2025) and the Best R&D Award from KEIT (2024). She has also received numerous academic honors, such as the Student Oral Presentation Award (2014), SYIS Oral Presentation Award (2014), and multiple scholarships recognizing her outstanding academic achievements during her graduate studies.

Research Focus πŸ”Ž

Dr. Kim’s research focuses on regenerative medicine, 3D bioprinting, and biomaterials. Her work involves developing patient-specific grafts using biocompatible scaffolds and hydrogels for tissue regeneration. She has pioneered innovations in vascularized adipose tissue regeneration, cartilage engineering, and self-assembling peptide nanofibers. Her ongoing projects include the commercialization of osteoimmune composite materials and development of ECM bioinks, contributing significantly to advancements in healthcare materials and personalized medicine.

Publication Top Notes

πŸ“š Development of Polycaprolactone Grafts with Improved Physical Properties and Body Stability using a Screw Extrusion-type 3D Bioprinter – International Journal of Bioprinting, 2022

πŸ“š Novel Chitosan Dermal Filler with Enhanced Moldability and Elasticity – Macromolecular Bioscience, 2022

πŸ“š Self-assembling Peptide Gels Promote Angiogenesis and Functional Recovery after Spinal Cord Injury in Rats – Journal of Tissue Engineering, 2022

πŸ“š The Regeneration of Large-Sized and Vascularized Adipose Tissue Using a Tailored Elastic Scaffold and dECM Hydrogels – International Journal of Molecular Sciences, 2021

πŸ“š Detection of Lysyl Oxidase Activity in Tumor Extracellular Matrix Using Peptide-Functionalized Gold Nanoprobes – Cancers, 2021

πŸ“š Study on the Direct Melting Extrusion Metal 3D Printing Using Induction Heating – Journal of the Korean Society of Manufacturing Technology Engineers, 2020

πŸ“š Vascularization of PLGA-Based Bio-Artificial Beds by Hypoxia-Preconditioned Mesenchymal Stem Cells for Subcutaneous Xenogeneic Islet Transplantation – Xenotransplantation, 2018

πŸ“š Skin Regeneration with a Scaffold of Predefined Shape and Bioactive Peptide Hydrogels – Tissue Engineering Part A, 2018 (Cited by: -)

πŸ“š TGF-Ξ²3 Encapsulated PLCL Scaffold by a Supercritical CO2-HFIP Co-Solvent System for Cartilage Tissue Engineering – Journal of Controlled Release, 2015

πŸ“š Self-Assembling Peptide Nanofibers Coupled with Neuropeptide Substance P for Bone Tissue Engineering – Tissue Engineering: Part A, 2015

 

Yanhong Duo | Bio-nanomedicine Award | Women Researcher Award

Published on by Academic Awards

Dr. Yanhong Duo | Bio-nanomedicine Award | Women Researcher Award

Dr. Yanhong Duo, Research Institute of Tsinghua University in Shenzhen, China

Yanhong Duo, Ph.D., is a distinguished researcher with expertise in nanomedicine and cancer therapy. With a background spanning prestigious institutions like Harvard University and Karolinska Institutet, Duo has made significant contributions to the field, particularly in developing innovative cancer treatment strategies. Notably, Duo has authored several groundbreaking publications in renowned journals, showcasing their prowess in aggregation-induced emission (AIE) technology and its applications in cancer therapy. Passionate about bridging cutting-edge research with clinical practice, Duo’s work promises to revolutionize personalized cancer treatment. πŸŽ“πŸ”¬

Publication Profile

Scopus

Education

Dr. Yanhong Duo, an accomplished scholar, has traversed a remarkable academic journey, culminating in their current position as a Visiting Assistant Professor of Nanomedicine at Harvard University, under the mentorship of esteemed Professor David A. Weitz. With a Ph.D. from Tsinghua University/Lanzhou University, focusing on cell biology under the guidance of Prof. Laiqiang Huang, Dr. Duo honed their expertise. They further expanded their research horizon during a postdoctoral tenure at Karolinska Institutet, investigating tumor blood vessels and brown fat under Prof. Yihai Cao. Their academic trajectory, from Bachelor’s studies in Molecular Biology at Northwest A&F University to their present prestigious role, reflects a steadfast commitment to advancing biomedical sciences. πŸ“šπŸ”¬

Research Focus

Dr. Yanhong Duo research focuses on advancing nanomedicine with a keen emphasis on developing innovative strategies for cancer treatment and immunotherapy. Their work delves into the development of novel carrier-free nanodrugs, supramolecular nano-twin-drugs, and targeted drug delivery systems using aggregation-induced emission (AIE) luminogens. They also explore the intersection of nanotechnology and immunotherapy, aiming to enhance the efficacy of cancer treatments while minimizing side effects. Through their investigations, Dr. Duo aims to illuminate new pathways for combating cancer, offering hope for improved patient outcomes. πŸ§¬πŸ”¬ Their multidisciplinary approach integrates nanotechnology, immunology, and oncology, paving the way for transformative advancements in cancer therapeutics.

 

Publication Top NotesΒ